Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update
Source: Substance Abuse and Mental Health Services Administration (SAMHSA)
Resource Type: Documents and Publications
Focus Population: People in Recovery from Substance Use
Topics: Recovery from Mental Health or Substance Use Disorders
This advisory summarizes data on the use of sublingual and transmucosal buprenorphine as part of medication-assisted treatment (MAT) for opioid use disorder.